Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Corcept Therapeutics Inc (NASDAQ:CORT)

6.50
Delayed Data
As of Sep 30
 +0.20 / +3.17%
Today’s Change
3.22
Today|||52-Week Range
6.72
+30.52%
Year-to-Date
Top 3 Growth Stocks Under $10
Sep 29 / Zacks.com - Paid Partner Content
Glaxo/J&J File BLA for Rheumatoid Arthritis Drug in the U.S.
Sep 26 / Zacks.com - Paid Partner Content
PAREXEL International (PRXL) Set to Acquire ExecuPharm
Sep 27 / Zacks.com - Paid Partner Content
Edwards Lifesciences, DaVita HealthCare Partners, Corcept Therapeutics and CryoLife h...
Sep 22 / Zacks.com - Paid Partner Content
Ionis/Biogen Complete Nusinersen NDA Submission in U.S.
Sep 27 / Zacks.com - Paid Partner Content
Here are 2 Momentous Healthcare Stocks to Buy Now
Sep 21 / Zacks.com - Paid Partner Content
Array (ARRY) Hits 52-Week High on Positive Phase III Data
Sep 27 / Zacks.com - Paid Partner Content
Adamas (ADMS) Parkinson's Disease Drug Positive in Phase III
Sep 21 / Zacks.com - Paid Partner Content
Novartis Ilaris Approved for Extended Use in Periodic Fever
Sep 26 / Zacks.com - Paid Partner Content
Aldeyra Therapeutics (ALDX) Worth a Look: Stock Gains 7%
Sep 21 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close6.30
Today’s open6.30
Day’s range6.26 - 6.55
Volume580,965
Average volume (3 months)356,761
Market cap$718.9M
Dividend yield--
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)+80.65%
Earnings growth (this year)+129.17%
Earnings growth (next 5 years)+49.29%
Revenue growth (last year)+89.39%
P/E ratio650.0
Price/Sales10.59
Price/Book38.53

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...+0.38+2.34%
CLCDCoLucid Pharmaceutic...+3.41+9.82%
ZIOPZIOPHARM Oncology In...+0.05+0.90%
TBRATobira Therapeutics ...+0.25+0.63%
Data as of 3:59pm ET, 09/30/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)$0.01
Annual revenue (last year)$50.3M
Annual profit (last year)-$6.4M
Net profit margin-12.74%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer, Director &
MD
Joseph K. Belanoff
Secretary &
Chief Financial Officer
Gary Charles Robb
Corporate headquarters
Menlo Park, California

Forecasts

Search for Jobs